These emerging therapies , Tirzepatide , represent a groundbreaking advancement in managing obesity and conceivably other conditions . They are categorized as GLP-1 receptor agonists , meaning they to emulate the endogenous GLP-1 peptide, boosting glucose release and suppressing food intake. Desp